• Users Online: 2529
  • Home
  • Print this page
  • Email this page

    Article Cited by others


Results of screening for retinopathy of prematurity in a large nursery in Kuwait: Incidence and risk factors

Wani Vivek B, Kumar Niranjan, Sabti Khalid, Raizada Seemant, Rashwan Nabeel, Shukkur Mumtaz M, Harbi Mohammed

Year : 2010| Volume: 58| Issue : 3 | Page no: 204-208

   This article has been cited by
1 Off-label use of intravitreal bevacizumab for severe retinopathy of prematurity
L.E. Alba,R.A. Zaldua,R.A. Masini
Archivos de la Sociedad Española de Oftalmología (English Edition). 2015;
[Pubmed]  [Google Scholar] [DOI]
2 Uso off-label de bevacizumab intravítreo en retinopatía del prematuro severa
L.E. Alba,R.A. Zaldua,R.A. Masini
Archivos de la Sociedad Española de Oftalmología. 2014;
[Pubmed]  [Google Scholar] [DOI]
3 The Incidence and Risk Factors of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants in Turkey
Ahmet Yagmur Bas
Medical Science Monitor. 2014; 20: 1647
[Pubmed]  [Google Scholar] [DOI]
4 Retinopathy of Prematurity-Incidence Today
Andrea Zin,Glen A. Gole
Clinics in Perinatology. 2013; 40(2): 185
[Pubmed]  [Google Scholar] [DOI]
5 Incidence of Retinopathy of Prematurity and Risk Factors Among Premature Infants at a Neonatal Intensive Care Unit in Canada
Gloria Isaza,Sourabh Arora,Manpartap Bal,Varun Chaudhary
Journal of Pediatric Ophthalmology & Strabismus. 2013; 50(1): 27
[Pubmed]  [Google Scholar] [DOI]
6 Early experience with intravitreal bevacizumab combined with laser treatment for retinopathy of prematurity
Raizada, S., Al Kandari, J., Al Foudari, A.
Middle East African Journal of Ophthalmology. 2011; 18(2): 196-197
[Pubmed]  [Google Scholar]


Read this article